Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 44 | 159 | 44 | 48 | 31 |
| Gross Profit | 44 | 159 | 44 | 48 | 31 |
| Operating Expenses | 5,434 | 4,969 | 5,422 | 6,851 | 4,900 |
| Operating Income | -5,390 | -4,810 | -5,379 | -6,803 | -4,869 |
| Other Income | -1,549 | 29 | -222 | -1,437 | -715 |
| Pre-tax Income | -6,940 | -4,781 | -5,601 | -8,240 | -5,584 |
| Net Income Continuous | -6,940 | -4,781 | -5,601 | -8,240 | -5,584 |
| Net Income Discontinuous | 0 | 0 | 0 | 1 | -1 |
| Minority Interests | -182 | -167 | -287 | -248 | -249 |
| Net Income | $-6,758 | $-4,614 | $-5,314 | $-7,992 | $-5,335 |
| EPS Basic Total Ops | -0.41 | -0.33 | -0.44 | -0.71 | -0.50 |
| EPS Basic Continuous Ops | -0.42 | -0.33 | -0.44 | -0.71 | -0.50 |
| EPS Diluted Total Ops | -0.41 | -0.33 | -0.44 | -0.71 | -0.50 |
| EPS Diluted Continuous Ops | -0.42 | -0.33 | -0.44 | -0.71 | -0.50 |
| EBITDA(a) | $-4,905 | $-4,360 | $-4,901 | $-6,406 | $-4,442 |